ASP Isotopes (NASDAQ:ASPI) Shares Down 5.2% - Here's What Happened

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shares fell 5.2% during trading on Wednesday . The company traded as low as $7.35 and last traded at $7.29. 505,183 shares were traded during mid-day trading, a decline of 82% from the average session volume of 2,801,312 shares. The stock had previously closed at $7.69.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upped their price target on ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a research note on Wednesday, May 21st.

ASP Isotopes Price Performance

The firm has a fifty day moving average price of $7.04 and a two-hundred day moving average price of $5.68. The company has a quick ratio of 7.17, a current ratio of 7.21 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $594.25 million, a P/E ratio of -11.65 and a beta of 3.56.

Insider Activity at ASP Isotopes

In other ASP Isotopes news, CEO Paul Elliot Mann sold 316,666 shares of ASP Isotopes stock in a transaction on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $1,779,662.92. Following the completion of the sale, the chief executive officer now owns 7,315,454 shares of the company's stock, valued at approximately $41,112,851.48. This trade represents a 4.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Robert Ainscow sold 66,666 shares of the company's stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total value of $383,329.50. Following the transaction, the chief operating officer now directly owns 1,553,326 shares in the company, valued at approximately $8,931,624.50. The trade was a 4.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 766,667 shares of company stock valued at $4,358,502. 21.40% of the stock is owned by insiders.

Institutional Investors Weigh In On ASP Isotopes

Large investors have recently bought and sold shares of the business. BNP Paribas Financial Markets bought a new position in ASP Isotopes during the 4th quarter valued at about $34,000. SBI Securities Co. Ltd. raised its holdings in shares of ASP Isotopes by 84.8% during the first quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after purchasing an additional 4,299 shares during the last quarter. Avantax Advisory Services Inc. purchased a new position in shares of ASP Isotopes during the fourth quarter valued at approximately $45,000. Russell Investments Group Ltd. lifted its position in ASP Isotopes by 56.3% during the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock valued at $46,000 after purchasing an additional 3,682 shares during the period. Finally, SVB Wealth LLC purchased a new stake in ASP Isotopes in the fourth quarter worth approximately $49,000. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.